Medicare drug worth negotiation is right here. The utmost truthful costs (MFP) set by Medicare result in reductions between 38% and 79%. In truth, the actual reductions are bigger for the reason that figures listed within the desk beneath are reductions off of 2023 costs (moderately than 2024 costs).
How did the negotiation course of work? CMS’s truth sheet described the method as follows:
CMS held three conferences with every taking part drug firm to debate the presents and counteroffers, talk about proof, and try to arrive at a mutually acceptable worth for the drug. Throughout the course of the negotiation course of, CMS revised its presents for every of the medicine upward in response to those discussions. Likewise, many drug corporations revised their counteroffers for his or her medicine downward, primarily based on the discussions with CMS. For 5 of the chosen medicine, this means of exchanging revised presents and counteroffers resulted in CMS and the drug firm reaching an settlement on a negotiated worth for the drug in affiliation with a negotiation assembly. In 4 of those instances, CMS accepted a revised counteroffer proposed by the drug firm. For the remaining 5 chosen medicine, CMS despatched a written closing supply to these drug corporations, in line with the method described in its steering, and in every occasion, the drug firm accepted CMS’s supply on or earlier than the statutory deadline.
However how precisely did CMS arrive at these costs? This isn’t clear. In truth, CMS mentioned it gained’t make public an evidence of the agreed-upon negotiated costs till March 2025.
Extra particulars on the MFP negotiation timeline is beneath.
What info and sources have been utilized in setting the MFP? Related info included:
…producer=submitted information on analysis and growth prices, prior federal monetary assist, unit prices of manufacturing and distribution, market/income/gross sales information, and knowledge on patents, FDA exclusivities, and FDA functions and approvals. For the elements listed at part 1194(e)(2) associated to proof about different therapies (together with therapeutic advances, prescribing info, comparative effectiveness, and unmet medical want), CMS thought of info from all kinds of sources, together with: info submitted by taking part drug corporations, folks with Medicare, tutorial consultants, clinicians, caregivers, and different events…; info offered on the Affected person-Targeted Listening Periods…; info shared by taking part drug corporations throughout conferences with CMS; and knowledge CMS recognized from its personal literature searches, together with from medical pointers and revealed research.
The negotiated costs will probably be efficient January 1, 2026.